Clinical Trial Update: Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a Phase 1 study evaluating relugolix in men with metastatic castration-sensitive and castration-resista…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Castration-sensitive Prostate Cancer
• Non-metastatic Castration-resistant Prostate Cancer

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer | Phase 1 | Status: COMPLETED